Magazine Article | May 9, 2017

Journey To The Corporate Boardroom

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL


If you have never served on a corporate board, you might be curious as to what it all entails. Thanks to BioBreak and Drexel University, Life Science Leader undertook the development of a threepart series of articles titled “Journey To The Corporate Boardroom.” Part 1 explored how to seek a board opportunity, while Part 2 dug into what leaders should be thinking about when building their company boards. In this final installment, we delve into what serving on a corporate board is really like. For insights we engaged the following five executives: Richard Baron, former CFO and board member of Zynerba Pharmaceuticals; Rich Daly, president, CEO, and chairman of the board for Neuralstem; Don Hayden, former global pharmaceuticals president for Bristol-Myers Squibb and current board member of several biopharmaceutical companies; Kirk Gorman, former CFO and EVP of Jefferson Health Systems and board member of several companies; and Gwen Melincoff, founder of Gemini Advisors and board member for Kamada Pharmaceuticals and former board member of Tobira Therapeutics.